표적 항암 치료제로써의 면역 조절자 VSIG4에 대한 인간항체 개발

Cited 0 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.author박성섭-
dc.coverage.temporal20151017-20161016-
dc.date.accessioned2017-04-19T11:49:13Z-
dc.date.available2017-04-19T11:49:13Z-
dc.date.issued2017-01-04-
dc.identifier.otherC12P 19/04(2009.09), C12P 19/16(2009.09)ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/14138-
dc.format.extent102-
dc.publisher미래창조과학부-
dc.title표적 항암 치료제로써의 면역 조절자 VSIG4에 대한 인간항체 개발-
dc.title.alternativeMethod for Preparing Ascorbic Acid 2-Glucoside Using Glucansucraseko
dc.typePatent-
dc.identifier.islinkhttp://link.kipris.or.kr/link/main/FullDoc.jsp?reg_key=4jLn6RaAi84A7NL71xinaQ%3D%3D=&APPLNO=1020090076848ko
dc.contributor.affiliatedAuthor박성섭-
dc.contributor.alternativeNameSung Sup Park-
dc.identifier.patentApplicationNumber10-2009-0076848ko
dc.identifier.patentRegistrationNumber10-1073990-0000ko
dc.identifier.ndslTRKO201800006173-
dc.description.sponsorshipAwardTitle표적 항암 치료제로써의 면역 조절자 VSIG4에 대한 인간항체 개발-
dcterms.contributor.director박성섭-
dc.contributor.director박성섭-
Appears in Collections:
Aging Convergence Research Center > 3. Research Reports
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.